Comparison Between Subtotal Parathyroidectomy and Total Parathyroidectomy with Autotransplantation for Secondary Hyperparathyroidism in Patients with Chronic Renal Failure: A Meta-Analysis

J. Chen; Q.-Y. Zhou; J.-D. Wang

doi:10.1055/s-0035-1554689

Hormone and Metabolic Research, Inhaltsverzeichnis

Horm Metab Res 2015; 47(09): 643-651
DOI: 10.1055/s-0035-1554689

Endocrine Care

Comparison Between Subtotal Parathyroidectomy and Total Parathyroidectomy with Autotransplantation for Secondary Hyperparathyroidism in Patients with Chronic Renal Failure: A Meta-Analysis

Authors

J. Chen^*

¹Department of Head and Neck Surgery, RenJi Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China
Q.-Y. Zhou^*

¹Department of Head and Neck Surgery, RenJi Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China
J.-D. Wang

¹Department of Head and Neck Surgery, RenJi Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China

Abstract

We conducted a meta-analysis of randomized and 2-arm prospective or retrospective studies that compared the efficacy of PTX and TPTX+AT in patients with medically uncontrollable secondary HPT due to chronic renal failure. Citations were identified in the Medline, Cochrane, EMBASE, and Google Scholar databases through April 2014. The primary outcome of interest was HPT recurrence rate, while secondary outcomes included changes in serum calcium (Ca⁺⁺), parathyroid hormone (PTH), alkaline phosphatase (ALP), and phosphate (P) levels. Five studies were included in the present analysis. The NOS score of all the included studies was 7 or above, and heterogeneity among the studies was minimal for 3 of the 5 outcomes. The HPT recurrence rate was similar for patients who underwent SPTX vs. TPTX+AT [odds ratio (OR)=0.825; 95% confidence interval (CI)=0.368 to 1.846; p=0.639]. The changes in serum Ca⁺⁺, PTH, ALP, and P were also similar between the 2 treatment groups (Ca⁺⁺: Std diff in means=− 0.166; 95% CI=− 0.703 to 0.371; p=0.545; PTH: pooled diff in means=561.17; 95% CI=–174.30 to 1296.6; p=0.135; ALP: pooled diff in means=0.58; 95% CI=− 70.07 to 71.24; p=0.987; P: pooled Std diff in means=0.26; 95% CI=− 0.091 to 0.630; p=0.143). Our findings indicate that SPTX and TPTX+AT are equally successful in preventing recurrent HPT and improving secondary HPT. We therefore, conclude that the choice of procedure can be left to the surgeons.

Key words

surgical treatment - hyperparathyroidism - chronic renal failure - parathyroidectomy - chronic kidney disease

Volltext

Referenzen

References
1 Douthat WG, Castellano M, Berenguer L, Guzmán MA, de Arteaga J, Chiurchiu CR, Massari PU, Garay G, Capra R, de La Fuente JL. High prevalence of secondary hyperparathyroidism in chronic kidney disease patients on dialysis in Argentina. Nefrologia 2013; 33: 657-666
2 Fernandez-Martin JL, Carrero JJ, Benedik M, Bos WJ, Covic A, Ferreira A, Floege J, Goldsmith D, Gorriz JL, Ketteler M, Kramar R, Locatelli F, London G, Martin PY, Memmos D, Nagy J, Naves-Díaz M, Pavlovic D, Rodríguez-García M, Rutkowski B, Teplan V, Tielemans C, Verbeelen D, Wüthrich RP, Martínez-Camblor P, Cabezas-Rodriguez I, Sánchez-Alvarez JE, Cannata-Andia JB. COSMOS: the dialysis scenario of CKD-MBD in Europe. Nephrol Dial Transplant 2013; 28: 1922-1935
3 Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44 (Suppl. 02) 34-38
4 Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005; 67: 1179-1187
5 Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, Badawi A. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 2013; 185: E417-E423
6 Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
7 Cueto-Manzano AM, Cortes-Sanabria L, Martinez-Ramirez HR, Rojas-Campos E, Gomez-Navarro B, Castillero-Manzano M. Prevalence of chronic kidney disease in an adult population. Arch Med Res 2014; 45: 507-513
8 Lee SW, Kim YC, Oh SW, Koo HS, Na KY, Chae DW, Kim S, Chin HJ. Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES). Nephrol Dial Transplant 2011; 26: 3975-3980
9 Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012; 379: 815-822
10 Nugent RA, Fathima SF, Feigl AB, Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract 2011; 118: c269-c277
11 Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 2011; 6: 913-921
12 Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm 2007; 13: 397-411
13 Fassbinder W, Brunner FP, Brynger H, Ehrich JH, Geerlings W, Raine AE, Rizzoni G, Selwood NH, Tufveson G, Wing AJ. Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant 1991; 6 (Suppl. 01) 5-35
14 Shih ML, Duh QY, Hsieh CB, Lin SH, Wu HS, Chu PL, Chen TY, Yu JC. Total parathyroidectomy without autotransplantation for secondary hyperparathyroidism. World J Surg 2009; 33: 248-254
15 Yano S, Sugimoto T, Tsukamoto T, Yamaguchi T, Hattori T, Sekita KI, Kaji H, Hattori S, Kobayashi A, Chihara K. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain. Horm Metab Res 2003; 35: 259-264
16 Hubbard JGH, Sebag F, Maweja S, Henry JF. Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg 2006; 141: 235-239
17 Committee K . KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; 113: S1-S130
18 Steddon S, Sharples E. Clinical Practice Guideline CKD-Mineral and Bone Disorders (CKD-MBD). UK Renal Association 2010;
19 Alveryd A. Parathyroid glands in thyroid surgery. I. Anatomy of parathyroid glands. II. Postoperative hypoparathyroidism-identification and autotransplantation of parathyroid glands. Acta Chir Scand 1968; 389: 1-120
20 Stanbury SW, Lumb GA, Nicholson WF. Elective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet 1960; 1: 793-799
21 Wells SA, Gunnells JC, Shelburne JD, Schneider AB, Sherwood LM. Transplantation of the parathyroid glands in man: clinical indications and results. Surgery 1975; 78: 34-44
22 Wells GSB, O'Connell D, Peterson J, Welch V, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. The 3rd Symposium on Systematic Reviews: Beyond the Basics. Oxford; England: 2000
23 Charhon SA, Berland YF, Olmer MJ, Delawari E, Traeger J, Meunier PJ. Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients. Kidney Int 1985; 27: 426-435
24 Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Medicine 1997; 127: 820-826
25 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statist Med 2002; 21: 1539-1558
26 DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
27 Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000; 320: 1574-1577
28 Gagne ER, Urena P, Leite-Silva S, Zingraff J, Chevalier A, Sarfati E, Dubost C, Drueke TB. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol 1992; 3: 1008-1017
29 Nichols P, Owen JP, Ellis HA, Farndon JR, Kelly PJ, Ward MK. Parathyroidectomy in chronic renal failure: a nine-year follow-up study. Q J Med 1990; 77: 1175-1193
30 Schneider R, Slater EP, Karakas E, Bartsch DK, Schlosser K. Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg 2012; 36: 318-326
31 Rothmund M, Wagner PK, Schark C. Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 1991; 15: 745-750
32 Kuo LE, Wachtel H, Karakousis G, Fraker D, Kelz R. Parathyroidectomy in dialysis patients. J Surg Res 2014; 190: 554-558
33 Richards ML, Wormuth J, Bingener J, Sirinek K. Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management?. Surgery 2006; 139: 174-180
34 Schneider R, Bartsch DK, Schlosser K. Relevance of bilateral cervical thymectomy in patients with renal hyperparathyroidism: analysis of 161 patients undergoing reoperative parathyroidectomy. World J Surg 2013; 37: 2155-2161
35 Schneider R, Waldmann J, Ramaswamy A, Fernandez ED, Bartsch DK, Schlosser K. Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy. World J Surg 2011; 35: 1260-1265
36 Gasparri G, Camandona M, Abbona GC, Papotti M, Jeantet A, Radice E, Mullineris B, Dei Poli M. Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg 2001; 233: 65-69
37 Tanaka Y, Seo H, Tominaga Y, Funahashi H, Matsui N, Takagi H. Factors related to the recurrent hyperfunction of autografts after total parathyroidectomy in patients with severe secondary hyperparathyroidism. Surg Today 1993; 23: 220-227
38 Tominaga Y, Tanaka Y, Sato K, Numano M, Uchida K, Falkmer U, Grimelius L, Johansson H, Takagi H. Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue. World J Surg 1992; 16: 595-602 discussion 602–593
39 Tominaga Y, Kohara S, Namii Y, Nagasaka T, Haba T, Uchida K, Numano M, Tanaka Y, Takagi H. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 1996; 20: 744-750
40 Neyer U, Hoerandner H, Haid A, Zimmermann G, Niederle B. Total parathyroidectomy with autotransplantation in renal hyperparathyroidism: low recurrence after intra-operative tissue selection. Nephrol Dial Transplant 2002; 17: 625-629
41 Niederle B, Horandner H, Roka R, Woloszczuk W. Morphologic and functional studies to prevent graft-dependent recurrence in renal osteodystrophy. Surgery 1989; 106: 1043-1048
42 Kuo LE, Wachtel H, Fraker D, Kelz R. Reoperative parathyroidectomy: who is at risk and what is the risk?. J Surg Res 2014; 191: 256-261
43 Low T-HH, Clark J, Gao K, Eris J, Shannon K, O’Brien C. Outcome of parathyroidectomy for patients with renal disease and hyperparathyroidism: predictors for recurrent hyperparathyroidism. ANZ J Surg 2009; 79: 378-382